Tong-Yu Lin

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

Seok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard et al. · The Lancet Oncology · 2016 · 386 citations · Full text

Medicine, Clinical Sciences, Oncology +15

Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Zhiming Li, Jia-Jia Huang, Yi Xia et al. · PLoS ONE · 2012 · 147 citations · Full text

Medicine, Hematology, Oncology +13

Long-term tumor-free survival from treatment with the GFP–TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells

Tong-Yu Lin, Xuefeng Huang, Jian Gu et al. · Oncogene · 2002 · 110 citations

Medicine, Molecular Biology, Oncology +13

Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial

Chang Liu, Zhi Peng, Yanqiao Zhang et al. · The Lancet · 2025 · 105 citations · Full text

Medicine, Oncology, Gastroenterology +8

Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.

Tong-Yu Lin, Jian Gu, Lidong Zhang et al. · PubMed · 2002 · 90 citations

Life Sciences, Molecular Biology, Oncology +17